JERAYGO

Medicinal product

(Invented) name

JERAYGO

Active substance (s)

Aprocitentanas

Strength

12,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C02KN01, aprocitentan

Marketing authorisation holder

Idorsia Pharmaceuticals Deutschland GmbH, Vokietija

Date of authorisation

2024-06-27

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Aprocitentanas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113992	100108	1100108	buteliukas	N30		Receptinis	EU/1/24/1818/001	Netiekiama	-	-	No	-	-
113994	100110	1100110	dalomoji lizdinė plokštelė	N10×1		Receptinis	EU/1/24/1818/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-06-27	Registruotas